STOCK TITAN

Novaccess Global Inc Financials

XSNX
Source SEC Filings (10-K/10-Q) Updated Sep 30, 2024 Currency USD FYE September

This page shows Novaccess Global Inc (XSNX) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 28 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Piotroski F-Score Weak
2/9

Novaccess Global Inc passes 2 of 9 financial strength tests. 2 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), neither operating efficiency signal passes.

Earnings Quality Low Quality
0.08x

For every $1 of reported earnings, Novaccess Global Inc generates $0.08 in operating cash flow (-$215K OCF vs -$2.7M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.

Interest Coverage At Risk
-1.4x

Novaccess Global Inc earns $-1.4 in operating income for every $1 of interest expense (-$902K vs $635K). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV
Revenue
$0

Novaccess Global Inc generated $0 in revenue in fiscal year 2024.

EBITDA
N/A
Free Cash Flow
N/A
Net Income
-$2.7M
YoY+43.7%

Novaccess Global Inc reported -$2.7M in net income in fiscal year 2024. This represents an increase of 43.7% from the prior year.

EPS (Diluted)
$-0.06
YoY+73.9%

Novaccess Global Inc earned $-0.06 per diluted share (EPS) in fiscal year 2024. This represents an increase of 73.9% from the prior year.

Cash & Debt
$21K
YoY-2.4%
5Y CAGR+21.3%
10Y CAGR-8.5%

Novaccess Global Inc held $21K in cash against $0 in long-term debt as of fiscal year 2024.

Dividends Per Share
N/A
Shares Outstanding
62M
YoY+184.7%

Novaccess Global Inc had 62M shares outstanding in fiscal year 2024. This represents an increase of 184.7% from the prior year.

Gross Margin
N/A
Operating Margin
N/A
Net Margin
N/A
Return on Equity
N/A
R&D Spending
$154K
YoY-0.3%

Novaccess Global Inc invested $154K in research and development in fiscal year 2024. This represents a decrease of 0.3% from the prior year.

Share Buybacks
N/A
Capital Expenditures
N/A

XSNX Income Statement

Metric Q3'24 Q2'24 Q1'23 Q3'23 Q2'23 Q1'22 Q3'22 Q2'22
Revenue $0 $0 $0 $0 $0 $0 $0 $0
Cost of Revenue $0 $0 $0 $0 $0 $0 $0 $0
Gross Profit $0 $0 $0 $0 $0 $0 $0 $0
R&D Expenses $37K+2.8% $36K-27.0% $50K+23.7% $40K-2.1% $41K+17.4% $35K-31.6% $51K+12.3% $46K
SG&A Expenses $278K+41.7% $196K-5.6% $208K-53.2% $444K-56.2% $1.0M+110.3% $482K+76.1% $274K-28.2% $381K
Operating Income -$315K-35.6% -$233K+9.7% -$258K+46.9% -$485K+54.1% -$1.1M-104.0% -$517K-59.2% -$325K+23.9% -$427K
Interest Expense $186K+74.4% $106K+48.3% $72K-75.7% $295K+12.5% $262K-12.7% $300K-42.3% $521K+103.8% $256K
Income Tax N/A N/A N/A N/A N/A N/A N/A N/A
Net Income -$936K-90.1% -$493K-137.8% $1.3M+267.2% -$780K-271.8% $454K+117.2% -$2.6M-463.9% -$467K+62.1% -$1.2M
EPS (Diluted) $-0.020.0% $-0.02-300.0% $0.01+125.0% $-0.04-33.3% $-0.03+78.6% $-0.14-366.7% $-0.03+62.5% $-0.08

XSNX Balance Sheet

Metric Q3'24 Q2'24 Q1'23 Q3'23 Q2'23 Q1'22 Q3'22 Q2'22
Total Assets $62K-27.3% $86K+394.0% $17K-72.1% $62K-39.8% $103K+76.7% $59K-53.1% $125K+49.6% $84K
Current Assets $62K N/A N/A $62K N/A N/A N/A N/A
Cash & Equivalents $21K+112.9% $10K+552.0% $2K-93.0% $21K-2.6% $22K-43.5% $39K-39.4% $64K+4.3% $62K
Inventory N/A N/A N/A N/A N/A N/A N/A N/A
Accounts Receivable N/A N/A N/A N/A N/A N/A N/A N/A
Goodwill N/A N/A N/A N/A N/A N/A N/A N/A
Total Liabilities $10.1M+45.3% $6.9M+7.6% $6.4M-18.0% $7.9M+34.8% $5.8M-17.7% $7.1M+48.3% $4.8M+2.1% $4.7M
Current Liabilities $10.1M+45.3% $6.9M+7.6% $6.4M-18.0% $7.9M+34.8% $5.8M-17.7% $7.1M+48.3% $4.8M+5.8% $4.5M
Long-Term Debt N/A N/A N/A N/A N/A N/A $166K0.0% $166K
Total Equity -$10.0M-46.2% -$6.9M-6.6% -$6.4M+17.6% -$7.8M-36.2% -$5.7M+18.5% -$7.0M-51.0% -$4.7M-1.2% -$4.6M
Retained Earnings -$69.6M-5.2% -$66.1M-0.8% -$65.6M+1.9% -$66.9M-4.0% -$64.4M+0.7% -$64.8M-4.2% -$62.2M-0.6% -$61.8M

XSNX Cash Flow Statement

Metric Q3'24 Q2'24 Q1'23 Q3'23 Q2'23 Q1'22 Q3'22 Q2'22
Operating Cash Flow -$55K+9.4% -$61K-53.3% -$40K+74.2% -$155K+21.5% -$197K-23.8% -$159K+19.4% -$198K+20.6% -$249K
Capital Expenditures N/A N/A N/A N/A N/A N/A N/A N/A
Free Cash Flow N/A N/A N/A N/A N/A N/A N/A N/A
Investing Cash Flow $0 N/A N/A $0 N/A N/A N/A N/A
Financing Cash Flow $76K+8.7% $70K+247.5% $20K-82.6% $115K-36.3% $180K+34.5% $134K-22.0% $172K-39.8% $286K
Dividends Paid N/A N/A N/A N/A N/A N/A N/A N/A
Share Buybacks N/A N/A N/A N/A N/A N/A N/A N/A

XSNX Financial Ratios

Metric Q3'24 Q2'24 Q1'23 Q3'23 Q2'23 Q1'22 Q3'22 Q2'22
Gross Margin N/A N/A N/A N/A N/A N/A N/A N/A
Operating Margin N/A N/A N/A N/A N/A N/A N/A N/A
Net Margin N/A N/A N/A N/A N/A N/A N/A N/A
Return on Equity N/A N/A N/A N/A N/A N/A N/A N/A
Return on Assets -342.3%+232.9pp -575.2%-8093.9pp 7518.7%+7959.1pp -440.4%-879.0pp 438.6%+4933.3pp -4494.8%-4248.4pp -246.3%+1226.3pp -1472.7%
Current Ratio 0.01 N/A N/A 0.01 N/A N/A N/A N/A
Debt-to-Equity -1.010.0 -1.010.0 -1.000.0 -1.01+0.0 -1.020.0 -1.01+0.0 -1.03-1.0 -0.04
FCF Margin N/A N/A N/A N/A N/A N/A N/A N/A

Note: Shareholder equity is negative (-$10.0M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Note: The current ratio is below 1.0 (0.01), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

Frequently Asked Questions

What is Novaccess Global Inc's annual revenue?

Novaccess Global Inc (XSNX) reported $0 in total revenue for fiscal year 2024. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

Is Novaccess Global Inc profitable?

No, Novaccess Global Inc (XSNX) reported a net income of -$2.7M in fiscal year 2024.

What is Novaccess Global Inc's earnings per share (EPS)?

Novaccess Global Inc (XSNX) reported diluted earnings per share of $-0.06 for fiscal year 2024. This represents a 73.9% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

What is Novaccess Global Inc's operating cash flow?

Novaccess Global Inc (XSNX) generated -$215K in operating cash flow during fiscal year 2024, representing cash generated from core business activities.

What are Novaccess Global Inc's total assets?

Novaccess Global Inc (XSNX) had $62K in total assets as of fiscal year 2024, including both current and long-term assets.

How much does Novaccess Global Inc spend on research and development?

Novaccess Global Inc (XSNX) invested $154K in research and development during fiscal year 2024.

How many shares does Novaccess Global Inc have outstanding?

Novaccess Global Inc (XSNX) had 62M shares outstanding as of fiscal year 2024.

What is Novaccess Global Inc's current ratio?

Novaccess Global Inc (XSNX) had a current ratio of 0.01 as of fiscal year 2024, which is below 1.0, which may suggest potential liquidity concerns.

What is Novaccess Global Inc's debt-to-equity ratio?

Novaccess Global Inc (XSNX) had a debt-to-equity ratio of -1.01 as of fiscal year 2024, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Novaccess Global Inc's return on assets (ROA)?

Novaccess Global Inc (XSNX) had a return on assets of -4271.5% for fiscal year 2024, measuring how efficiently the company uses its assets to generate profit.

What is Novaccess Global Inc's cash runway?

Based on fiscal year 2024 data, Novaccess Global Inc (XSNX) had $21K in cash against an annual operating cash burn of $215K. This gives an estimated cash runway of approximately 1 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.

Why is Novaccess Global Inc's debt-to-equity ratio negative or unusual?

Novaccess Global Inc (XSNX) has negative shareholder equity of -$10.0M as of fiscal year 2024, which causes the debt-to-equity ratio to appear negative or not meaningful. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

What is Novaccess Global Inc's Piotroski F-Score?

Novaccess Global Inc (XSNX) has a Piotroski F-Score of 2 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Novaccess Global Inc's earnings high quality?

Novaccess Global Inc (XSNX) has an earnings quality ratio of 0.08x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Novaccess Global Inc cover its interest payments?

Novaccess Global Inc (XSNX) has an interest coverage ratio of -1.4x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.